It is certainly still early days for the partial payments movement, and how far the market will move towards an entirely severity based product remains to be seen.
“But whether insurers choose to directly compete with PruProtect or not, they will have to continue to adapt as more and more medical advancements are made, and illness that were once deemed critical become less serious,” says OVISO’s Fullaway.